5HT2A/C serotonin blockade in Parkinson's disease

Trial Profile

5HT2A/C serotonin blockade in Parkinson's disease

Phase of Trial: Phase II

Latest Information Update: 31 Jan 2017

At a glance

  • Drugs Pimavanserin (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Nov 2007 Status changed from in progress to completed
    • 01 Sep 2006 Status change
    • 25 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top